Cervos Medical

Cervos Medical is advancing the field of autologous biologics with a philosophy that 'dose matters,' aiming to deliver superior regenerative outcomes through its portfolio of medical devices. The company's products, developed in collaboration with leading physicians, are designed to be minimally invasive, maximally efficient, and cost-effective, targeting a variety of musculoskeletal conditions. Cervos leverages clinical evidence to support its technologies, which eliminate the need for centrifugation in some processes, thereby streamlining procedures and improving product yield. Their strategic direction focuses on optimizing natural healing and expanding the application of their autologous biologic solutions in advanced care settings.

Platforms for centrifuge-free harvesting and high-yield concentration of autologous biologics, including bone marrow aspirate, platelet-rich plasma (PRP), bone graft, and adipose tissue, designed for minimally invasive procedures.

Cervos competes against major orthopedics firms like Arthrex, Zimmer Biomet, and Stryker, as well as specialized PRP/BMAC system providers. Its primary differentiation is the centrifuge-free bone marrow aspiration technology (Marrow Cellution™), which simplifies the procedure and aims to provide higher stem cell yields, coupled with a portfolio that addresses multiple orthobiologic needs from a single vendor.